跳至主要内容
临床试验/NCT03060889
NCT03060889已完成3 期

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial

Ain Shams University0 个研究点目标入组 86 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
86
主要终点
intra operative blood loss in ml

研究概览

简要总结

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

详细描述

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Term pregnancy (more than 37 weeks of gestation)
  • Diagnosis of placenta previa was confirmed by ultrasound
  • The patient hemoglobin percentage is more than 10 mg/dl

排除标准

  • Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies
  • Emergency lower segment cesarean section
  • Associated medical comorbidities

研究组 & 干预措施

Cases

Active Comparator

Tranexamic acid 10 mg/ kg body weight will be given by intravenous infusion with induction of anesthesia in elective cesarean section for non complicated cases of placenta previa

干预措施: Tranexamic acid (Drug)

结局指标

主要结局

intra operative blood loss in ml

时间窗: intraoperative during cesarean section

Calculation of blood loss during cesarean section in the two groups to detect efficacy of Tranexamic acid in reducing blood loss

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Elsayed Hassan Elbohoty

Principal Investigator

Ain Shams University

相似试验